Publication | Closed Access
The Akt/mTOR/p70S6K pathway is activated in IgA nephropathy and rapamycin may represent a viable treatment option
21
Citations
20
References
2015
Year
Glomerular DiseaseGlomerulonephritisRenal DiseaseAutoimmune DiseaseMedicineKidney FailureIga GlomerulonephritisImmunologyLupus NephritisPathologyAutoimmunityViable Treatment OptionChronic Kidney DiseaseNephrologyKidney ResearchAkt/mtor/p70s6k Pathway
| Year | Citations | |
|---|---|---|
Page 1
Page 1